Guided Therapeutics INC Form 4 insider transactions

OQB
Richard P. Blumberg, a director and 10% owner of Guided Therapeutics Inc., reports acquiring additional shares through the conversion of accrued dividends from Series F and F-2 preferred stock.
OQB
Richard P. Blumberg, a director and 10% owner of Guided Therapeutics, acquired shares and warrants as part of a consulting agreement.